These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31495556)

  • 1. In vitro cytotoxicity screening to identify novel anti-osteosarcoma therapeutics targeting pyruvate dehydrogenase kinase 2.
    Cao W; Wang Z; Han X; Liu J; Wang W
    Bioorg Med Chem Lett; 2019 Oct; 29(20):126665. PubMed ID: 31495556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel pyruvate dehydrogenase kinases inhibitors by screening of an in-house small molecule library for anti-lung cancer therapeutics.
    Guo F; Zhao S; Li X
    Bioorg Med Chem Lett; 2019 Jan; 29(2):291-296. PubMed ID: 30470491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biological evaluation and structure-activity relationship of novel dichloroacetophenones targeting pyruvate dehydrogenase kinases with potent anticancer activity.
    Xu B; Wang ZP; Liu Q; Yang X; Li X; Huang D; Qiu Y; Tam KY; Zhang SL; He Y
    Eur J Med Chem; 2021 Mar; 214():113225. PubMed ID: 33550182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Novel Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors by Kinase Activity-Based High-Throughput Screening for Anticancer Therapeutics.
    Zhang W; Hu X; Chakravarty H; Yang Z; Tam KY
    ACS Comb Sci; 2018 Nov; 20(11):660-671. PubMed ID: 30350563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of pyruvate dehydrogenase kinase 1 inhibitors with anti-osteosarcoma activity.
    Fang A; Luo H; Liu L; Fan H; Zhou Y; Yao Y; Zhang Y
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5450-5453. PubMed ID: 29150396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of dual inhibitors targeting pyruvate dehydrogenase kinases and human lactate dehydrogenase A: High-throughput virtual screening, synthesis and biological validation.
    Xiang S; Huang D; He Q; Li J; Tam KY; Zhang SL; He Y
    Eur J Med Chem; 2020 Oct; 203():112579. PubMed ID: 32688200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy.
    Anwar S; Shamsi A; Mohammad T; Islam A; Hassan MI
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188568. PubMed ID: 34023419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput screening of novel pyruvate dehydrogenase kinases inhibitors and biological evaluation of their in vitro and in vivo antiproliferative activity.
    Wu DM; Wang YJ; Fan SH; Zhang ZF; Shan Q; Lu J; Chen GQ; Zheng YL
    Eur J Med Chem; 2019 Feb; 164():252-262. PubMed ID: 30597326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for the inhibition of PDK2 by novel ATP- and lipoyl-binding site targeting compounds.
    Kang J; Pagire HS; Kang D; Song YH; Lee IK; Lee KT; Park CJ; Ahn JH; Kim J
    Biochem Biophys Res Commun; 2020 Jun; 527(3):778-784. PubMed ID: 32444142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dichloroacetophenones targeting at pyruvate dehydrogenase kinase 1 with improved selectivity and antiproliferative activity: Synthesis and structure-activity relationships.
    Zhang SL; Yang Z; Hu X; Tam KY
    Bioorg Med Chem Lett; 2018 Nov; 28(21):3441-3445. PubMed ID: 30266541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the pyruvate dehydrogenase complex/pyruvate dehydrogenase kinase (PDC/PDK) axis to discover potent PDK inhibitors through structure-based virtual screening and pharmacological evaluation.
    Gan L; Yang Y; Liang Z; Zhang M; He Y; Zhang SL
    Eur J Med Chem; 2024 Jan; 264():116008. PubMed ID: 38056298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced antitumor potential induced by chloroacetate-loaded benzophenones acting as fused tubulin-pyruvate dehydrogenase kinase 1 (PDHK1) ligands.
    Ghinet A; Thuru X; Floquet E; Dubois J; Farce A; Rigo B
    Bioorg Chem; 2020 Mar; 96():103643. PubMed ID: 32035298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of novel human lactate dehydrogenase A inhibitors: High-throughput screening, synthesis, and biological evaluations.
    Zhou Y; Tao P; Wang M; Xu P; Lu W; Lei P; You Q
    Eur J Med Chem; 2019 Sep; 177():105-115. PubMed ID: 31129449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design of mitochondria-targeted pyruvate dehydrogenase kinase 1 inhibitors with improved selectivity and antiproliferative activity.
    Xu B; Yu Z; Xiang S; Li Y; Zhang SL; He Y
    Eur J Med Chem; 2018 Jul; 155():275-284. PubMed ID: 29890389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fructose-coated Angstrom silver inhibits osteosarcoma growth and metastasis via promoting ROS-dependent apoptosis through the alteration of glucose metabolism by inhibiting PDK.
    Hu XK; Rao SS; Tan YJ; Yin H; Luo MJ; Wang ZX; Zhou JH; Hong CG; Luo ZW; Du W; Wu B; Yan ZQ; He ZH; Liu ZZ; Cao J; Wang Y; Situ WY; Liu HM; Huang J; Wang YY; Xia K; Qian YX; Zhang Y; Yue T; Liu YW; Zhang HQ; Tang SY; Chen CY; Xie H
    Theranostics; 2020; 10(17):7710-7729. PubMed ID: 32685015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design, synthesis, pharmacophore modeling, and docking studies for identification of novel potent DNA-PK inhibitors.
    Ihmaid S; Ahmed HEA; Al-Sheikh Ali A; Sherif YE; Tarazi HM; Riyadh SM; Zayed MF; Abulkhair HS; Rateb HS
    Bioorg Chem; 2017 Jun; 72():234-247. PubMed ID: 28482264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial pyruvate dehydrogenase kinases contribute to platelet function and thrombosis in mice by regulating aerobic glycolysis.
    Flora GD; Nayak MK; Ghatge M; Kumskova M; Patel RB; Chauhan AK
    Blood Adv; 2023 Jun; 7(11):2347-2359. PubMed ID: 36971790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of potent dual PDK1/AurA kinase inhibitors for cancer therapy: Lead-optimization, structural insights, and ADME-Tox profile.
    Sestito S; Bacci A; Chiarugi S; Runfola M; Gado F; Margheritis E; Gul S; Riveiro ME; Vazquez R; Huguet S; Manera C; Rezai K; Garau G; Rapposelli S
    Eur J Med Chem; 2021 Dec; 226():113895. PubMed ID: 34624821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ilimaquinone Induces the Apoptotic Cell Death of Cancer Cells by Reducing Pyruvate Dehydrogenase Kinase 1 Activity.
    Kwak CH; Jin L; Han JH; Han CW; Kim E; Cho M; Chung TW; Bae SJ; Jang SB; Ha KT
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and structure-activity relationship of a focused library of β-phenylalanine derivatives as novel eEF2K inhibitors with apoptosis-inducing mechanisms in breast cancer.
    Guo Y; Zhao Y; Wang G; Chen Y; Jiang Y; Ouyang L; Liu B
    Eur J Med Chem; 2018 Jan; 143():402-418. PubMed ID: 29202403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.